Ivars Tolmanis

Ivars Tolmanis is an Assistant Professor at the Department of Internal Diseases, focusing on clinical medicine with a strong emphasis on gastroenterology and colorectal cancer research. His work explores the intersection of gut microbiota, inflammatory bowel disease, and metabolic biomarkers.

• Active in clinical trials (e.g., QUASAR and LUCENT studies) for ulcerative colitis therapies
• Published extensively on colorectal cancer screening, Helicobacter pylori, and microbiome analysis
• Collaborates with researchers like Vilkoite, I. and Lejnieks, A. on gut microbiota-neoplasia associations

Research spans Gastroenterology, Colorectal Oncology, and Gut Microbiome Studies, with recent articles in The Lancet and New England Journal of Medicine evaluating biologics like Guselkumab and Mirikizumab. Trends include biomarker discovery and microbiome-driven disease mechanisms.

He supervises a PhD project on Colorectal Neoplasia and Gut Microbiota (2020–2024) and contributes to SDG 3.2 (Clinical Medicine) as an expert for the Latvian Council of Science (2018–2021, 2021–2024).